|
|
Volumn 341, Issue 5, 1999, Pages 362-363
|
|
Fever and neutropenia - How to use a new treatment strategy
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMIKACIN;
AMOXICILLIN PLUS CLAVULANIC ACID;
ANTIINFECTIVE AGENT;
CARBENICILLIN;
CEFTAZIDIME;
CEFTRIAXONE;
CIPROFLOXACIN;
GENTAMICIN;
PENICILLIN DERIVATIVE;
ANTIMICROBIAL THERAPY;
CANCER CHEMOTHERAPY;
DRUG CHOICE;
DRUG EFFICACY;
EDITORIAL;
FEBRILE NEUTROPENIA;
GRANULOCYTOPENIA;
HIGH RISK POPULATION;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RISK ASSESSMENT;
THROMBOCYTE TRANSFUSION;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
AGRANULOCYTOSIS;
ANTI-BACTERIAL AGENTS;
ANTINEOPLASTIC AGENTS;
FEVER;
HUMANS;
INFUSIONS, INTRAVENOUS;
NEOPLASMS;
NEUTROPENIA;
RISK ASSESSMENT;
|
|
EID: 0033614944
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM199907293410509 Document Type: Editorial |
|
Times cited : (49)
|
|
References (12)
|
